The dysregulation of HOXA7 in ESCC is associated with a poorer prognosis, echoing findings from mixed-lineage leukemia, where HOXA7 overexpression correlates with lower survival rates [34]. The gene discussed is HOXA7; the disease is esophageal squamous cell carcinoma.